Canakinumab

CAS : 914613-48-2

Ref. TM-T73695

Informations sur le produit

• Nom: Canakinumab
• Synonymes: ACZ 885, Ilaris
• CAS: 914613-48-2

Description

Canakinumab (ACZ885) is a recombinant human IL-1β-targeting monoclonal antibody.Canakinumab has been shown to inhibit human and chorioallantoic monkey IL-1β, with IC50 values of 43.6 and 40.8 pM, respectively.Canakinumab has anti-inflammatory activity, inhibiting inflammation associated with autoimmune diseases by neutralizing IL-1β signaling. Canakinumab has anti-inflammatory activity, inhibiting inflammation associated with autoimmune diseases by neutralizing IL-1β signaling.Canakinumab has been used for the treatment of gout and coronary artery disease.

• Marque: Targetmol

Propriétés chimiques

• Couleur/Forme: Solid